Felodipine repurposed for targeting TRPV1 receptor to relieve oral cancer pain

Oral Oncol. 2022 Nov:134:106094. doi: 10.1016/j.oraloncology.2022.106094. Epub 2022 Aug 26.
No abstract available

Keywords: Chemo informatics; Computational biology; Nociception; Oncology; Oral health-related quality of life.

Publication types

  • Letter

MeSH terms

  • Cancer Pain* / drug therapy
  • Felodipine
  • Humans
  • Mouth Neoplasms* / complications
  • Mouth Neoplasms* / drug therapy
  • Pain
  • TRPV Cation Channels

Substances

  • TRPV Cation Channels
  • TRPV1 protein, human
  • TRPV1 receptor
  • Felodipine